A pilot study of atorvastatin treatment in dyslipemid, non‐alcoholic fatty liver patients

Abstract

Serum aminotransferase and lipid levels were reduced significantly in all patients with atorvastatin treatment. Therapy with atorvastatin in NAFLD patients with hyperlipidemia was found to be both effective and safe.